Technology facilitating single cell cloning to help meet regulatory requirements

Patricia Fitzpatrick Diamond discusses recent technological advances aiding single cell cloning, including Solentim’s VIPS™, in GEN. To meet regulatory standards, recombinant proteins must be produced from a single cell line, demonstrating monoclonality whilst maintaining viability. This is a slow and involved process, with commonly used methods exhibiting significant draw backs. Limiting dilution retains the viability …

Read more Technology facilitating single cell cloning to help meet regulatory requirements

Janssen Pharma to present VIPS data at major conference

Customer data presentation at the Bioprocessing Summit in Boston NEWS – Bournemouth, UK – 30th July, 2018: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce that Janssen Pharmaceutical (part of Johnson & Johnson) will be presenting data from the VIPS single cell seeding platform at the forthcoming CHI 10th Annual Bioprocessing Summit in Boston. …

Read more Janssen Pharma to present VIPS data at major conference

Solentim at the Palace

This week, members of Solentim’s management team enjoyed the privileged experience of visiting Buckingham Palace. The invitation to a private reception at the Palace followed Solentim’s success in winning two Queen’s Awards for Enterprise, announced in April, the first for Innovation and the second for International Trade. The reception was hosted by The Prince of …

Read more Solentim at the Palace

Conference Report on latest trends in Cell Line Development and Cell Culture

A summary of the Informa Cell Line Development & Engineering conference, held in Amsterdam in April 2018. April 23rd-25th, 2018 Amsterdam: I recently attended the annual Informa Cell Line Development & Engineering conference, held in Amsterdam over the course of three days. I went in eager anticipation of listening to a wide range of pharmaceutical companies and …

Read more Conference Report on latest trends in Cell Line Development and Cell Culture

Solentim awarded two Queen’s Awards for Enterprise

Solentim, based in Bournemouth, Dorset, is delighted to have been given awards for both International Trade and Innovation. PRESS RELEASE – 21st April, 2018, BOURNEMOUTH: Dorset-based Solentim awarded two Queen’s Awards for Enterprise The Queen’s Awards for Enterprise are the UK’s most prestigious business awards, given only to companies or individuals who are outstanding in their …

Read more Solentim awarded two Queen’s Awards for Enterprise

Clonality webinar draws a crowd

“Higher confidence of clonality” theme resonates with customers NEWS – Bournemouth, UK – 10th April 2018: Solentim, the innovator and leader in Cell Line Development instrumentation, successfully hosted an educational webinar entitled “Higher Confidence of Clonality” on March 22nd. The webinar featured the world’s first fully automated system for Single Cell Cloning, which is called …

Read more Clonality webinar draws a crowd